Fortrea Holdings (FTRE) Cash from Operations (2022 - 2026)
Fortrea Holdings' (FTRE) quarterly Cash from Operations came in at 28900000.0 in Q2 2026, up 32.57% YoY from 21800000.0 in Q2 2025, and up 270.0% on a QoQ basis from 17000000.0 in Q1 2026.
Fortrea Holdings (FTRE) Cash from Operations (2022 - 2026) Analysis & Trends
Fortrea Holdings (FTRE) has 5 years of Cash from Operations data on file, last reported at 28900000.0 in Q2 2026.
- Quarterly Cash from Operations rose 32.57% year-over-year to 28900000.0 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 227800000.0 (up 359.75% YoY) and the FY2025 annual result came in at 113500000.0, down 56.81% from the prior year.
- Cash from Operations rose to 28900000.0 in Q2 2026, from 17000000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 273700000.0 in Q2 2024 to a low of 124200000.0 in Q1 2025.
- A 5-year average of 41312500.0 and a median of 20100000.0 in 2023 frame the typical range for Cash from Operations.
- Annual changes were most pronounced in 2024 — Cash from Operations sank 1180.0% — and 2025, when it surged 3716.67%.
- Tracing FTRE's Cash from Operations over 5 years: stood at 23500000.0 in 2022, then fell by 21.7% to 18400000.0 in 2023, then decreased by 7.07% to 17100000.0 in 2024, then surged by 654.97% to 129100000.0 in 2025, then slumped by 77.61% to 28900000.0 in 2026.
- The last three Cash from Operations figures came in at 28900000.0 (Q2 2026), 17000000.0 (Q1 2026), and 129100000.0 (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -387.32 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 462.82 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -1.76 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 728.46 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 326.72 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -88.83 Mn |
| 10 | Fortrea Holdings | 1.66 Bn | 1.49 Bn | 139.20 Mn | 28.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 28.90 Mn |
| Jun 30, 2026 | 28.90 Mn |
| Mar 31, 2026 | -17.00 Mn |
| Mar 31, 2026 | -17.00 Mn |
| Dec 31, 2025 | 129.10 Mn |
| Dec 31, 2025 | 129.10 Mn |
| Sep 30, 2025 | 86.80 Mn |
| Sep 30, 2025 | 86.80 Mn |
| Jun 30, 2025 | 21.80 Mn |
| Jun 30, 2025 | 21.80 Mn |
| Mar 31, 2025 | -124.20 Mn |
| Mar 31, 2025 | -124.20 Mn |
| Dec 31, 2024 | 17.10 Mn |
| Dec 31, 2024 | 17.10 Mn |
| Sep 30, 2024 | -2.40 Mn |
| Sep 30, 2024 | -2.40 Mn |
| Jun 30, 2024 | 273.70 Mn |
| Jun 30, 2024 | 273.70 Mn |
| Mar 31, 2024 | -25.60 Mn |
| Mar 31, 2024 | -25.60 Mn |